Leukocyte Growth Factor [EPC]

Leukocyte Growth Factor [EPC] was reported 142787 times

These side effects are most commonly reported by patients taking drugs of the Leukocyte Growth Factor [EPC] class:

# Drug class Count
0 DEVICE ADHESION ISSUE 11940
1 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10370
2 UNINTENTIONAL MEDICAL DEVICE REMOVAL 8999
3 FEBRILE NEUTROPENIA 8113
4 DEVICE MALFUNCTION 7891
5 OFF LABEL USE 7143
6 NEUTROPENIA 6186
7 DEVICE USE ERROR 6087
8 DEATH 6025
9 PYREXIA 5498
10 DEVICE ISSUE 5310
11 ACCIDENTAL EXPOSURE TO PRODUCT 5107
12 NAUSEA 4616
13 FATIGUE 4590
14 DIARRHOEA 4463
15 BONE PAIN 3938
16 DEVICE OCCLUSION 3406
17 ANAEMIA 3219
18 THROMBOCYTOPENIA 3092
19 PNEUMONIA 3076
20 VOMITING 3013
21 DYSPNOEA 2921
22 WHITE BLOOD CELL COUNT DECREASED 2845
23 PAIN 2745
24 ASTHENIA 2350
25 DRUG INEFFECTIVE 2304
26 SEPSIS 2290
27 ALOPECIA 2271
28 DRUG DOSE OMISSION 2202
29 DRUG DOSE OMISSION BY DEVICE 2185
30 PANCYTOPENIA 1966
31 BACK PAIN 1862
32 HEADACHE 1784
33 NEUTROPHIL COUNT DECREASED 1784
34 PLATELET COUNT DECREASED 1776
35 DECREASED APPETITE 1713
36 RASH 1712
37 MALAISE 1693
38 ARTHRALGIA 1658
39 INFECTION 1643
40 NEUROPATHY PERIPHERAL 1631
41 CONSTIPATION 1602
42 INTERCEPTED PRODUCT PREPARATION ERROR 1580
43 ABDOMINAL PAIN 1497
44 DEVICE LEAKAGE 1490
45 DISEASE PROGRESSION 1479
46 HYPOTENSION 1469
47 OCCUPATIONAL EXPOSURE TO PRODUCT 1425
48 DEVICE PHYSICAL PROPERTY ISSUE 1422
49 APPLICATION SITE HAEMORRHAGE 1398
50 COUGH 1374
51 DIZZINESS 1358
52 HYPERHIDROSIS 1338
53 HOSPITALISATION 1324
54 LEUKOPENIA 1316
55 PAIN IN EXTREMITY 1314
56 APPLICATION SITE PAIN 1285
57 PRODUCT STORAGE ERROR 1275
58 DEHYDRATION 1265
59 MUCOSAL INFLAMMATION 1257
60 WEIGHT DECREASED 1180
61 HAEMOGLOBIN DECREASED 1151
62 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1124
63 UNDERDOSE 1107
64 CHEST PAIN 1101
65 MYALGIA 1078
66 ACUTE KIDNEY INJURY 1060
67 URINARY TRACT INFECTION 1021
68 SEPTIC SHOCK 995
69 GENERAL PHYSICAL HEALTH DETERIORATION 993
70 RESPIRATORY FAILURE 946
71 PRODUCT USE IN UNAPPROVED INDICATION 912
72 HYPOKALAEMIA 904
73 DEVICE FAILURE 883
74 FALL 881
75 STOMATITIS 881
76 NO ADVERSE EVENT 871
77 PRURITUS 848
78 PLEURAL EFFUSION 844
79 CHILLS 821
80 INSOMNIA 790
81 ANXIETY 784
82 ATRIAL FIBRILLATION 778
83 WHITE BLOOD CELL COUNT INCREASED 777
84 PULMONARY EMBOLISM 766
85 OEDEMA PERIPHERAL 736
86 RENAL FAILURE 730
87 ERYTHEMA 727
88 SYNCOPE 721
89 CYTOKINE RELEASE SYNDROME 714
90 MALIGNANT NEOPLASM PROGRESSION 710
91 TACHYCARDIA 697
92 CONDITION AGGRAVATED 695
93 ABDOMINAL PAIN UPPER 676
94 FEELING ABNORMAL 674
95 CONFUSIONAL STATE 665
96 NEUTROPENIC SEPSIS 663
97 HYPERSENSITIVITY 662
98 NEEDLE ISSUE 660
99 HYPERTENSION 655
100 CELLULITIS 648
101 PARAESTHESIA 636
102 HYPOAESTHESIA 617
103 BACTERIAL INFECTION 615
104 EPISTAXIS 607
105 UNEVALUABLE EVENT 598
106 DEEP VEIN THROMBOSIS 591
107 INJECTION SITE PAIN 588
108 HYPONATRAEMIA 585
109 BONE MARROW FAILURE 580
110 HYPOXIA 578
111 PRODUCT PREPARATION ERROR 566
112 COVID-19 563
113 LEUKOCYTOSIS 561
114 MUSCLE SPASMS 551
115 ACUTE MYELOID LEUKAEMIA 548
116 INCORRECT DOSE ADMINISTERED 530
117 INCORRECT DOSE ADMINISTERED BY DEVICE 530
118 PLASMA CELL MYELOMA 528
119 COLITIS 527
120 ALANINE AMINOTRANSFERASE INCREASED 526
121 CLOSTRIDIUM DIFFICILE COLITIS 526
122 PRODUCT DOSE OMISSION 522
123 MULTIPLE ORGAN DYSFUNCTION SYNDROME 499
124 OROPHARYNGEAL PAIN 499
125 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 496
126 DEVICE POWER SOURCE ISSUE 486
127 LYMPHADENOPATHY 486
128 BLOOD CREATININE INCREASED 482
129 THROMBOSIS 479
130 CARDIAC FAILURE 474
131 PNEUMONITIS 471
132 ASPARTATE AMINOTRANSFERASE INCREASED 466
133 PRODUCT DOSE OMISSION ISSUE 464
134 INTERSTITIAL LUNG DISEASE 457
135 ADVERSE EVENT 455
136 PSYCHOLOGICAL TRAUMA 452
137 DYSPHAGIA 451
138 C-REACTIVE PROTEIN INCREASED 448
139 URTICARIA 441
140 CHEST DISCOMFORT 440
141 HAIR COLOUR CHANGES 440
142 HAIR TEXTURE ABNORMAL 440
143 VIRAL INFECTION 437
144 MYELODYSPLASTIC SYNDROME 434
145 INTERCEPTED PRODUCT ADMINISTRATION ERROR 432
146 MUSCULOSKELETAL PAIN 432
147 WHITE BLOOD CELL COUNT ABNORMAL 431
148 NASOPHARYNGITIS 429
149 PRODUCT USE ISSUE 427
150 APPLICATION SITE DISCOMFORT 420
151 LOSS OF CONSCIOUSNESS 419
152 GAIT DISTURBANCE 418
153 DYSGEUSIA 417
154 DEPRESSION 413
155 MUSCULAR WEAKNESS 413
156 DEVICE ELECTRICAL FINDING 409
157 TOXICITY TO VARIOUS AGENTS 408
158 PERIPHERAL SWELLING 404
159 ABDOMINAL DISTENSION 401
160 LYMPHOPENIA 400
161 MADAROSIS 398
162 FUNGAL INFECTION 397
163 INVESTIGATION 396
164 GASTROINTESTINAL DISORDER 387
165 DEVICE DELIVERY SYSTEM ISSUE 384
166 RENAL IMPAIRMENT 381
167 INFLUENZA LIKE ILLNESS 377
168 ABDOMINAL DISCOMFORT 375
169 DYSPEPSIA 375
170 DRUG HYPERSENSITIVITY 373
171 HYPERGLYCAEMIA 373
172 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 373
173 WEIGHT INCREASED 372
174 TREMOR 371
175 SOMNOLENCE 368
176 UPPER RESPIRATORY TRACT INFECTION 368
177 NEOPLASM MALIGNANT 366
178 OEDEMA 364
179 RED BLOOD CELL COUNT DECREASED 362
180 ACUTE RESPIRATORY DISTRESS SYNDROME 361
181 NEUTROPHIL COUNT ABNORMAL 361
182 PRODUCT COMMUNICATION ISSUE 361
183 INCORRECT DISPOSAL OF PRODUCT 360
184 CYTOMEGALOVIRUS INFECTION 359
185 AGRANULOCYTOSIS 356
186 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 352
187 PALPITATIONS 352
188 NEOPLASM PROGRESSION 348
189 HAIR DISORDER 347
190 HEART RATE INCREASED 341
191 THERAPY NON-RESPONDER 341
192 STAPHYLOCOCCAL INFECTION 338
193 DRUG INTERACTION 333
194 GASTROINTESTINAL HAEMORRHAGE 331
195 ASCITES 330
196 MYELOSUPPRESSION 330
197 RENAL FAILURE ACUTE 328
198 BACTERAEMIA 327
199 CARDIAC ARREST 326
200 LOWER RESPIRATORY TRACT INFECTION 324
201 DRY SKIN 323
202 FLUSHING 323
203 BRONCHOPULMONARY ASPERGILLOSIS 321
204 CYTOPENIA 319
205 INFLUENZA 319
206 EMOTIONAL DISTRESS 315
207 HAEMORRHAGE 313
208 ORAL PAIN 313
209 SPLENOMEGALY 311
210 SINUSITIS 310
211 LETHARGY 308
212 INFUSION RELATED REACTION 304
213 ADVERSE DRUG REACTION 303
214 ATELECTASIS 302
215 BLOOD PRESSURE DECREASED 300
216 CONTUSION 299
217 HERPES ZOSTER 295
218 SEIZURE 293
219 RASH MACULO-PAPULAR 291
220 BLOOD LACTATE DEHYDROGENASE INCREASED 287
221 LUNG DISORDER 285
222 CANDIDA INFECTION 284
223 RHINORRHOEA 284
224 NECK PAIN 283
225 CLOSTRIDIUM DIFFICILE INFECTION 281
226 MEMORY IMPAIRMENT 281
227 BLOOD ALKALINE PHOSPHATASE INCREASED 279
228 APPLICATION SITE BRUISE 278
229 DRUG INTOLERANCE 277
230 PSEUDOMONAL SEPSIS 275
231 THERAPY PARTIAL RESPONDER 274
232 HYPOALBUMINAEMIA 273
233 HAEMATOTOXICITY 272
234 CYTOMEGALOVIRUS VIRAEMIA 271
235 STAPHYLOCOCCAL BACTERAEMIA 270
236 BLOOD BILIRUBIN INCREASED 268
237 HAEMATOCRIT DECREASED 267
238 MYOCARDIAL INFARCTION 267
239 SWELLING FACE 266
240 BRONCHITIS 265
241 PRODUCTIVE COUGH 265
242 DEVICE RELATED INFECTION 263
243 HYPOMAGNESAEMIA 262
244 NEUTROPHIL COUNT INCREASED 262
245 OXYGEN SATURATION DECREASED 262
246 PULMONARY OEDEMA 261
247 HOT FLUSH 257
248 MULTI-ORGAN FAILURE 257
249 ORAL CANDIDIASIS 256
250 EJECTION FRACTION DECREASED 255
251 FULL BLOOD COUNT DECREASED 254
252 ANAPHYLACTIC REACTION 253
253 MOBILITY DECREASED 253
254 PERIPHERAL SENSORY NEUROPATHY 253
255 VISION BLURRED 253
256 ARRHYTHMIA 251
257 DYSPNOEA EXERTIONAL 251
258 CEREBROVASCULAR ACCIDENT 250
259 LABORATORY TEST ABNORMAL 246
260 DISEASE RECURRENCE 245
261 INFLAMMATION 245
262 ACUTE RESPIRATORY FAILURE 243
263 CARDIAC FAILURE CONGESTIVE 243
264 FEBRILE BONE MARROW APLASIA 243
265 VISUAL IMPAIRMENT 243
266 HYPOCALCAEMIA 242
267 NEUROTOXICITY 242
268 PAIN IN JAW 239
269 SECONDARY IMMUNODEFICIENCY 239
270 BLOOD PRESSURE INCREASED 236
271 APLASTIC ANAEMIA 235
272 BLOOD POTASSIUM DECREASED 235
273 TUMOUR LYSIS SYNDROME 235
274 GAMMA-GLUTAMYLTRANSFERASE INCREASED 233
275 HAEMATURIA 232
276 SKIN EXFOLIATION 232
277 BODY TEMPERATURE INCREASED 231
278 ENTERITIS 231
279 OVERDOSE 231
280 METASTASES TO LIVER 228
281 NIGHT SWEATS 228
282 CYSTITIS 227
283 JOINT SWELLING 227
284 ORAL HERPES 227
285 THERAPEUTIC RESPONSE DECREASED 227
286 SWELLING 225
287 RESPIRATORY DISTRESS 224
288 LYMPHOCYTE COUNT DECREASED 222
289 HEPATIC FAILURE 220
290 GASTROOESOPHAGEAL REFLUX DISEASE 219
291 HYPOTHYROIDISM 218
292 INTENTIONAL PRODUCT USE ISSUE 217
293 HYPOPHAGIA 216
294 DEVICE ALARM ISSUE 214
295 LUNG INFILTRATION 213
296 HEPATOTOXICITY 212
297 BLOOD GLUCOSE INCREASED 211
298 GRAFT VERSUS HOST DISEASE 210
299 LIVER DISORDER 210
300 POLYNEUROPATHY 210
301 RESPIRATORY TRACT INFECTION 210
302 MOUTH ULCERATION 209
303 RASH PRURITIC 208
304 DISCOMFORT 207
305 HEPATIC ENZYME INCREASED 205
306 CARDIAC DISORDER 204
307 ESCHERICHIA INFECTION 204
308 BLOOD COUNT ABNORMAL 203
309 DEVICE PLACEMENT ISSUE 201
310 MENTAL STATUS CHANGES 201
311 ENCEPHALOPATHY 200
312 METASTASES TO BONE 200
313 METASTASES TO CENTRAL NERVOUS SYSTEM 200
314 NEUTROPENIC COLITIS 199
315 DRY MOUTH 198
316 SLEEP DISORDER 198
317 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 198
318 ACUTE GRAFT VERSUS HOST DISEASE 197
319 DEVICE DEPLOYMENT ISSUE 197
320 FEELING HOT 197
321 SINUS TACHYCARDIA 196
322 ACUTE MYELOID LEUKAEMIA RECURRENT 195
323 DYSURIA 193
324 INJECTION SITE HAEMORRHAGE 191
325 MATERNAL EXPOSURE DURING PREGNANCY 191
326 PSEUDOMONAS INFECTION 191
327 DYSPHONIA 190
328 ILLNESS 190
329 AORTITIS 189
330 VENOOCCLUSIVE LIVER DISEASE 189
331 COGNITIVE DISORDER 188
332 DRUG DELIVERY SYSTEM MALFUNCTION 188
333 CEREBRAL HAEMORRHAGE 186
334 PERICARDIAL EFFUSION 185
335 RHINOVIRUS INFECTION 185
336 RECTAL HAEMORRHAGE 184
337 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 183
338 BREAST CANCER 181
339 TRANSFUSION 181
340 RASH ERYTHEMATOUS 180
341 TRANSAMINASES INCREASED 180
342 DEVICE DISLOCATION 179
343 HEPATIC FUNCTION ABNORMAL 179
344 IMPAIRED QUALITY OF LIFE 178
345 LYMPHOMA 178
346 PNEUMOCYSTIS JIROVECII PNEUMONIA 178
347 VASCULITIS 178
348 SKIN LESION 177
349 LACRIMATION INCREASED 176
350 OSTEONECROSIS OF JAW 176
351 MUSCULOSKELETAL CHEST PAIN 173
352 ARTHRITIS 172
353 CYSTITIS HAEMORRHAGIC 171
354 HERPES SIMPLEX 170
355 THROMBOTIC MICROANGIOPATHY 170
356 HUMAN HERPESVIRUS 6 INFECTION 169
357 MYCOBACTERIUM CHELONAE INFECTION 169
358 HYPOPHOSPHATAEMIA 168
359 PARAINFLUENZAE VIRUS INFECTION 168
360 HAEMOPTYSIS 166
361 BALANCE DISORDER 165
362 CONVULSION 165
363 HYPERKALAEMIA 165
364 HYPOACUSIS 164
365 DEVICE DEFECTIVE 160
366 DIFFUSE LARGE B-CELL LYMPHOMA 160
367 ELECTROLYTE IMBALANCE 160
368 NEURALGIA 160
369 BLISTER 159
370 ILL-DEFINED DISORDER 159
371 LUNG INFECTION 159
372 DISSEMINATED INTRAVASCULAR COAGULATION 158
373 ENTEROBACTER INFECTION 158
374 TREATMENT FAILURE 158
375 GASTRITIS 157
376 OESOPHAGITIS 157
377 PULMONARY TOXICITY 157
378 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 157
379 RESPIRATORY DISORDER 156
380 PULMONARY FIBROSIS 155
381 APPLICATION SITE ERYTHEMA 154
382 ASPERGILLUS INFECTION 154
383 KLEBSIELLA INFECTION 154
384 ESCHERICHIA BACTERAEMIA 153
385 RESTLESSNESS 153
386 STAPHYLOCOCCAL SEPSIS 152
387 CARDIO-RESPIRATORY ARREST 151
388 TOXIC EPIDERMAL NECROLYSIS 151
389 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 150
390 LYMPHOID TISSUE HYPOPLASIA 149
391 BLOOD MAGNESIUM DECREASED 148
392 SPINAL PAIN 148
393 CHEMOTHERAPY 147
394 FACE OEDEMA 147
395 THYMUS HYPOPLASIA 147
396 HAEMORRHOIDS 146
397 HYPERBILIRUBINAEMIA 146
398 ILEUS 146
399 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 146
400 HAEMATOCHEZIA 145
401 SKIN DISCOLOURATION 145
402 ENTEROCOCCAL INFECTION 144
403 PNEUMATOSIS INTESTINALIS 144
404 BURNING SENSATION 143
405 WHEEZING 143
406 BONE DISORDER 142
407 CHRONIC GRAFT VERSUS HOST DISEASE 142
408 HYPERCALCAEMIA 142
409 INJECTION SITE ERYTHEMA 142
410 DELIRIUM 141
411 INTENTIONAL PRODUCT MISUSE 141
412 FLUID RETENTION 140
413 SKIN ULCER 140
414 CIRCULATORY COLLAPSE 139
415 COAGULOPATHY 139
416 POLLAKIURIA 139
417 PROTEINURIA 139
418 DEVICE DIFFICULT TO USE 138
419 LIVER FUNCTION TEST ABNORMAL 138
420 PRESYNCOPE 138
421 GASTROENTERITIS 137
422 OESOPHAGEAL CANDIDIASIS 137
423 BLOOD UREA INCREASED 136
424 BREAST CANCER METASTATIC 136
425 MIGRAINE 136
426 NO THERAPEUTIC RESPONSE 136
427 PNEUMOTHORAX 136
428 SKIN TOXICITY 136
429 METABOLIC ACIDOSIS 135
430 METASTASES TO LYMPH NODES 135
431 SURGERY 135
432 FOETAL EXPOSURE DURING PREGNANCY 134
433 HAEMATOMA 134
434 LIMB DISCOMFORT 134
435 NEPHROPATHY TOXIC 134
436 URINARY RETENTION 134
437 EMBOLISM 133
438 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 132
439 PALLOR 132
440 SPEECH DISORDER 132
441 FLATULENCE 131
442 OSTEOMYELITIS 131
443 MUSCULOSKELETAL STIFFNESS 130
444 PNEUMONIA ASPIRATION 130
445 UNRESPONSIVE TO STIMULI 129
446 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 128
447 INTESTINAL OBSTRUCTION 128
448 PNEUMONIA FUNGAL 128
449 PREMATURE BABY 128
450 SKIN DISORDER 128
451 DIVERTICULITIS 127
452 IMPAIRED HEALING 127
453 ECZEMA 125
454 METASTASES TO LUNG 125
455 PULMONARY HAEMORRHAGE 125
456 EAR PAIN 124
457 HUMAN BOCAVIRUS INFECTION 124
458 HYPOGAMMAGLOBULINAEMIA 124
459 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 124
460 LEFT VENTRICULAR DYSFUNCTION 124
461 RASH GENERALISED 124
462 VERTIGO 124
463 ACUTE MYOCARDIAL INFARCTION 123
464 APHASIA 123
465 CYTOMEGALOVIRUS INFECTION REACTIVATION 123
466 INJURY ASSOCIATED WITH DEVICE 123
467 NEUTROPENIC INFECTION 123
468 BLOOD SODIUM DECREASED 122
469 DIABETES MELLITUS 122
470 PANCREATITIS 122
471 COVID-19 PNEUMONIA 121
472 INJURY 121
473 RENAL DISORDER 121
474 CARDIOMYOPATHY 120
475 CYTOMEGALOVIRUS CHORIORETINITIS 120
476 VENOUS THROMBOSIS 120
477 APLASIA 119
478 HEPATIC STEATOSIS 119
479 INJECTION SITE REACTION 119
480 BLOOD DISORDER 118
481 JAUNDICE 118
482 DEPRESSED LEVEL OF CONSCIOUSNESS 117
483 HAEMORRHAGE INTRACRANIAL 117
484 LUNG NEOPLASM MALIGNANT 117
485 MEDICATION ERROR 117
486 MENINGITIS TUBERCULOUS 117
487 SHOCK 117
488 BRAIN OEDEMA 116
489 HALLUCINATION 116
490 OSTEOARTHRITIS 116
491 TACHYPNOEA 115
492 URINARY INCONTINENCE 115
493 BLOOD CULTURE POSITIVE 114
494 LYMPHOEDEMA 114
495 CATARACT 113
496 DISORIENTATION 113
497 NASAL CONGESTION 113
498 OSTEONECROSIS 113
499 SECOND PRIMARY MALIGNANCY 113
500 SMALL INTESTINAL OBSTRUCTION 113
501 SPLENIC RUPTURE 113
502 ANAPHYLACTIC SHOCK 112
503 ANOREXIA 112
504 BRADYCARDIA 112
505 INTERCEPTED MEDICATION ERROR 112
506 WOUND 112
507 CAPILLARY LEAK SYNDROME 111
508 CARDIOTOXICITY 111
509 ODYNOPHAGIA 111
510 AGITATION 110
511 CYSTITIS BACTERIAL 110
512 HYPOGLYCAEMIA 110
513 SKIN INFECTION 110
514 THERAPY INTERRUPTED 110
515 MALNUTRITION 109
516 NERVOUSNESS 109
517 WHITE BLOOD CELL DISORDER 109
518 CHOLELITHIASIS 108
519 CHOLESTASIS 108
520 ESCHERICHIA SEPSIS 108
521 HYDRONEPHROSIS 108
522 PULMONARY MASS 108
523 TINNITUS 108
524 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 107
525 PLATELET COUNT ABNORMAL 107
526 RESPIRATORY SYNCYTIAL VIRUS INFECTION 107
527 VASCULAR DEVICE INFECTION 107
528 ABSCESS 106
529 GASTROINTESTINAL TOXICITY 106
530 HAEMATEMESIS 106
531 VIRAEMIA 106
532 AMNESIA 105
533 PETECHIAE 105
534 SYRINGE ISSUE 105
535 DISSEMINATED ASPERGILLOSIS 104
536 FEELING COLD 104
537 STEM CELL TRANSPLANT 104
538 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 103
539 ASTHMA 102
540 BACTERIAL SEPSIS 102
541 LEUKAEMIA 102
542 ANGIOEDEMA 101
543 BLOOD TEST ABNORMAL 101
544 DEVICE MECHANICAL ISSUE 101
545 GENERALISED OEDEMA 101
546 REFUSAL OF TREATMENT BY PATIENT 101
547 SKIN REACTION 101
548 STEVENS-JOHNSON SYNDROME 101
549 INTESTINAL PERFORATION 100
550 NERVOUS SYSTEM DISORDER 100
551 OSTEOPOROSIS 100
552 CONJUNCTIVITIS 99
553 ENTEROCOLITIS 99
554 FEEDING DISORDER 99
555 PELVIC PAIN 99
556 STREPTOCOCCAL INFECTION 99
557 THERAPY CESSATION 99
558 CEREBRAL INFARCTION 98
559 ELECTROCARDIOGRAM QT PROLONGED 98
560 MUSCLE TWITCHING 98
561 PARONYCHIA 98
562 TENDERNESS 98
563 UROSEPSIS 98
564 DEAFNESS 96
565 DERMATITIS 96
566 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 96
567 NEPHROLITHIASIS 96
568 TOOTHACHE 96
569 FLUID OVERLOAD 95
570 HEPATIC CYTOLYSIS 95
571 BLOOD CALCIUM DECREASED 94
572 DRY EYE 94
573 EATING DISORDER 94
574 NOROVIRUS TEST POSITIVE 94
575 PULMONARY HYPERTENSION 94
576 SWOLLEN TONGUE 94
577 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 92
578 DIFFUSE ALVEOLAR DAMAGE 92
579 MELAENA 92
580 NON-HODGKIN^S LYMPHOMA 92
581 SKIN FISSURES 92
582 DEPRESSED MOOD 91
583 INCORRECT PRODUCT STORAGE 91
584 INTERVERTEBRAL DISC PROTRUSION 91
585 MUSCULOSKELETAL DISCOMFORT 91
586 SPINAL OSTEOARTHRITIS 91
587 TASTE DISORDER 91
588 TRANSIENT ISCHAEMIC ATTACK 91
589 GASTRIC ULCER 90
590 PERITONITIS 90
591 TOOTH DISORDER 90
592 AGEUSIA 89
593 THROAT TIGHTNESS 89
594 CHRONIC LYMPHOCYTIC LEUKAEMIA 88
595 ENCEPHALITIS 88
596 EPILEPSY 88
597 HODGKIN^S DISEASE 88
598 PLASMA CELL MYELOMA RECURRENT 88
599 PULMONARY CONGESTION 88
600 BK VIRUS INFECTION 87
601 BONE MARROW DISORDER 87
602 HICCUPS 87
603 ISCHAEMIC STROKE 87
604 NAIL DISORDER 87
605 RASH MACULAR 87
606 UPPER GASTROINTESTINAL HAEMORRHAGE 87
607 ABDOMINAL PAIN LOWER 86
608 LIP SWELLING 86
609 TRICUSPID VALVE INCOMPETENCE 86
610 COLONY STIMULATING FACTOR THERAPY 85
611 DYSSTASIA 85
612 EXPOSURE DURING PREGNANCY 85
613 HEPATITIS 85
614 INJECTION SITE BRUISING 85
615 MENTAL DISORDER 85
616 PHARYNGITIS 85
617 SUPRAVENTRICULAR TACHYCARDIA 84
618 BASAL CELL CARCINOMA 83
619 BLOOD ALBUMIN DECREASED 83
620 FLANK PAIN 83
621 HAEMOGLOBIN ABNORMAL 83
622 HEPATOMEGALY 83
623 LOCAL SWELLING 83
624 PLATELET COUNT INCREASED 83
625 THROAT IRRITATION 83
626 ACUTE LYMPHOCYTIC LEUKAEMIA 82
627 ADRENAL INSUFFICIENCY 82
628 CARDIOMEGALY 82
629 EYE SWELLING 82
630 PNEUMONIA BACTERIAL 82
631 RENAL CYST 82
632 STRESS 82
633 DRUG EFFECT INCOMPLETE 81
634 DRUG TOXICITY 81
635 DYSARTHRIA 81
636 MYOCARDITIS 81
637 NEUROBLASTOMA RECURRENT 81
638 PANCREATITIS ACUTE 81
639 SYSTEMIC CANDIDA 81
640 VENOOCCLUSIVE DISEASE 81
641 ARTHROPATHY 80
642 BONE LESION 80
643 HYPERTHERMIA 80
644 IMMUNOSUPPRESSION 80
645 PRODUCT QUALITY ISSUE 80
646 COMPUTERISED TOMOGRAM THORAX ABNORMAL 79
647 EOSINOPHILIA 79
648 MITRAL VALVE INCOMPETENCE 79
649 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 79
650 TOXIC SKIN ERUPTION 79
651 CHRONIC KIDNEY DISEASE 78
652 COMA 78
653 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 78
654 HODGKIN^S DISEASE RECURRENT 78
655 IMMUNODEFICIENCY 78
656 INCORRECT ROUTE OF DRUG ADMINISTRATION 78
657 LOCALISED INFECTION 77
658 DISTURBANCE IN ATTENTION 76
659 ORGANISING PNEUMONIA 76
660 ORTHOSTATIC HYPOTENSION 76
661 VAGINAL HAEMORRHAGE 76
662 ADENOVIRUS INFECTION 75
663 DERMATITIS ACNEIFORM 75
664 GLOSSODYNIA 75
665 IMMUNE SYSTEM DISORDER 75
666 LIVER FUNCTION TEST INCREASED 75
667 NEUTROPHILIA 75
668 PAIN OF SKIN 75
669 PNEUMONIA KLEBSIELLA 75
670 TREATMENT NONCOMPLIANCE 75
671 ULCER 75
672 ABDOMINAL TENDERNESS 74
673 CHOLECYSTITIS 74
674 FLUID INTAKE REDUCED 74
675 FULL BLOOD COUNT ABNORMAL 74
676 OSTEOPENIA 74
677 PHLEBITIS 74
678 SUBDURAL HAEMATOMA 74
679 VISUAL ACUITY REDUCED 74
680 HYPERTHYROIDISM 73
681 RASH PAPULAR 73
682 SUDDEN DEATH 73
683 VARICOSE VEIN 73
684 ALOPECIA AREATA 72
685 CACHEXIA 72
686 CYTOMEGALOVIRUS TEST POSITIVE 72
687 DECUBITUS ULCER 72
688 EXTRA DOSE ADMINISTERED 72
689 GRANULOCYTOPENIA 72
690 MULTIPLE MYELOMA 72
691 OCULAR HYPERAEMIA 72
692 PREMATURE DELIVERY 72
693 TOOTH INFECTION 72
694 TRANSPLANT FAILURE 72
695 ABSCESS BACTERIAL 71
696 ATRIAL FLUTTER 71
697 BLINDNESS 71
698 IRRITABILITY 71
699 MAGNETIC RESONANCE IMAGING 71
700 MASS 71
701 DEVICE BATTERY ISSUE 70
702 DRUG ERUPTION 70
703 EPSTEIN-BARR VIRUS INFECTION 70
704 HAEMOLYTIC ANAEMIA 70
705 HEART RATE ABNORMAL 70
706 TOOTH ABSCESS 70
707 ANGINA PECTORIS 69
708 ERYSIPELAS 69
709 PARAESTHESIA ORAL 69
710 RHABDOMYOLYSIS 69
711 STREPTOCOCCAL SEPSIS 69
712 GINGIVAL BLEEDING 68
713 HOSPICE CARE 68
714 INGUINAL HERNIA 68
715 POOR QUALITY SLEEP 68
716 RASH PUSTULAR 68
717 RIB FRACTURE 68
718 SPINAL FRACTURE 68
719 BLOOD STEM CELL HARVEST FAILURE 67
720 DRUG RESISTANCE 67
721 INJECTION SITE SWELLING 67
722 NON-CARDIAC CHEST PAIN 67
723 THROMBOPHLEBITIS 67
724 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 66
725 CHROMATURIA 66
726 HYPERLIPIDAEMIA 66
727 HYPOKINESIA 66
728 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 66
729 OSTEOLYSIS 66
730 SENSORY DISTURBANCE 66
731 BLOOD CREATINE PHOSPHOKINASE INCREASED 65
732 HAEMOLYSIS 65
733 HEMIPARESIS 65
734 PURPURA 65
735 RECURRENT CANCER 65
736 ADVERSE REACTION 64
737 APHTHOUS ULCER 64
738 APPLICATION SITE SWELLING 64
739 CORONARY ARTERY DISEASE 64
740 EYE DISORDER 64
741 NEOPLASM RECURRENCE 64
742 PERIPHERAL MOTOR NEUROPATHY 64
743 PLATELET TRANSFUSION 64
744 PYELONEPHRITIS 64
745 APPLICATION SITE DISCOLOURATION 63
746 ASPIRATION 63
747 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 63
748 PANCREATIC CARCINOMA 63
749 SLEEP APNOEA SYNDROME 63
750 VENTRICULAR TACHYCARDIA 63
751 WOUND INFECTION 63
752 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 62
753 HIP FRACTURE 62
754 HYPERPYREXIA 62
755 JOINT STIFFNESS 62
756 LARGE INTESTINE PERFORATION 62
757 PROCTALGIA 62
758 BREAST CANCER RECURRENT 61
759 CANDIDIASIS 61
760 CHRONIC SINUSITIS 61
761 CORONAVIRUS INFECTION 61
762 FAILURE TO THRIVE 61
763 GRAFT VERSUS HOST DISEASE IN SKIN 61
764 LACTIC ACIDOSIS 61
765 METASTASIS 61
766 MUSCULOSKELETAL DISORDER 61
767 MYOCARDIAL ISCHAEMIA 61
768 PHARYNGEAL OEDEMA 61
769 STREPTOCOCCAL BACTERAEMIA 61
770 SYSTEMIC INFECTION 61
771 TRANSPLANT REJECTION 61
772 ABASIA 60
773 BLOOD CREATINE INCREASED 60
774 EYE PAIN 60
775 FEBRILE INFECTION 60
776 HYPERURICAEMIA 60
777 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 60
778 INJECTION SITE DISCOMFORT 60
779 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 59
780 CORONA VIRUS INFECTION 59
781 ECCHYMOSIS 59
782 INTERNATIONAL NORMALISED RATIO INCREASED 59
783 LIMB INJURY 59
784 PERICARDITIS 59
785 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 59
786 PSEUDOMONAL BACTERAEMIA 59
787 RED CELL DISTRIBUTION WIDTH INCREASED 59
788 RETCHING 59
789 ALTERED STATE OF CONSCIOUSNESS 58
790 B-CELL LYMPHOMA 58
791 COLITIS ISCHAEMIC 58
792 DIARRHOEA HAEMORRHAGIC 58
793 EAR INFECTION 58
794 HEAD INJURY 58
795 INTRACARDIAC THROMBUS 58
796 OBESITY 58
797 ORAL DISORDER 58
798 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 58
799 SARS-COV-2 TEST POSITIVE 58
800 SPUTUM DISCOLOURED 58
801 BRONCHOSPASM 57
802 DEMENTIA 57
803 ENGRAFTMENT SYNDROME 57
804 ESCHERICHIA URINARY TRACT INFECTION 57
805 HEPATOCELLULAR INJURY 57
806 HYPERSOMNIA 57
807 HYPOVOLAEMIA 57
808 LYMPHADENITIS 57
809 PROSTATE CANCER 57
810 RESPIRATORY ARREST 57
811 ACNE 56
812 BLOOD URINE PRESENT 56
813 GINGIVAL PAIN 56
814 HYPERTRIGLYCERIDAEMIA 56
815 LUNG CONSOLIDATION 56
816 NUCLEAR MAGNETIC RESONANCE IMAGING 56
817 PULMONARY ALVEOLAR HAEMORRHAGE 56
818 RADIOTHERAPY 56
819 SINUS DISORDER 56
820 SPINAL COMPRESSION FRACTURE 56
821 BLOOD URIC ACID INCREASED 55
822 BREAST PAIN 55
823 CLOSTRIDIAL INFECTION 55
824 GAIT INABILITY 55
825 GASTROINTESTINAL INFECTION 55
826 GOUT 55
827 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 55
828 INTERVERTEBRAL DISC DEGENERATION 55
829 NEOPLASM 55
830 RESPIRATORY RATE INCREASED 55
831 SERUM FERRITIN INCREASED 55
832 BEDRIDDEN 54
833 COLD SWEAT 54
834 DIALYSIS 54
835 DIPLOPIA 54
836 EYELID OEDEMA 54
837 FAECES DISCOLOURED 54
838 GASTROENTERITIS NOROVIRUS 54
839 SPLENIC INFARCTION 54
840 TONSILLITIS 54
841 ACUTE CORONARY SYNDROME 53
842 IRON DEFICIENCY ANAEMIA 53
843 KLEBSIELLA SEPSIS 53
844 LEUKAEMIA RECURRENT 53
845 LOW BIRTH WEIGHT BABY 53
846 PERIPHERAL COLDNESS 53
847 SQUAMOUS CELL CARCINOMA 53
848 TOOTH EXTRACTION 53
849 TOOTH LOSS 53
850 TRANSITIONAL CELL CARCINOMA 53
851 URINE OUTPUT DECREASED 53
852 ANHEDONIA 52
853 APPLICATION SITE PRURITUS 52
854 DENTAL CARIES 52
855 DRUG-INDUCED LIVER INJURY 52
856 GENE MUTATION 52
857 KLEBSIELLA BACTERAEMIA 52
858 METASTASES TO SPINE 52
859 POOR QUALITY DEVICE USED 52
860 PULMONARY THROMBOSIS 52
861 ARTERITIS 51
862 BLOOD LACTIC ACID INCREASED 51
863 DERMATITIS BULLOUS 51
864 DIVERTICULUM 51
865 DRUG ADMINISTRATION ERROR 51
866 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 51
867 MUSCLE ATROPHY 51
868 OSTEOSCLEROSIS 51
869 PNEUMOCYSTIS JIROVECI PNEUMONIA 51
870 ROAD TRAFFIC ACCIDENT 51
871 SCAR 51
872 SENSORY LOSS 51
873 THERAPEUTIC PRODUCT EFFECT DECREASED 51
874 VENTRICULAR FIBRILLATION 51
875 ABORTION SPONTANEOUS 50
876 ALVEOLITIS 50
877 APPLICATION SITE IRRITATION 50
878 CARDIOVASCULAR DISORDER 50
879 COLON CANCER 50
880 FIBRIN D DIMER INCREASED 50
881 GASTRIC DISORDER 50
882 HEART RATE IRREGULAR 50
883 HERPES VIRUS INFECTION 50
884 HIATUS HERNIA 50
885 LOWER LIMB FRACTURE 50
886 SUBARACHNOID HAEMORRHAGE 50
887 TISSUE INFILTRATION 50
888 TONGUE ULCERATION 50
889 WRONG DRUG ADMINISTERED 50
890 BONE MARROW TRANSPLANT 49
891 CARDIOGENIC SHOCK 49
892 DERMATITIS ALLERGIC 49
893 FACIAL PAIN 49
894 HYPERTRANSAMINASAEMIA 49
895 LIPASE INCREASED 49
896 NAIL DISCOLOURATION 49
897 PATHOLOGICAL FRACTURE 49
898 PHOTOPHOBIA 49
899 PHOTOSENSITIVITY REACTION 49
900 PROTEIN TOTAL DECREASED 49
901 RHINITIS 49
902 SUBCLAVIAN VEIN THROMBOSIS 49
903 ACTIVITIES OF DAILY LIVING IMPAIRED 48
904 CENTRAL VENOUS CATHETERISATION 48
905 CYANOSIS 48
906 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 48
907 HEPATIC LESION 48
908 HEPATOSPLENOMEGALY 48
909 NECROSIS 48
910 PERIORBITAL OEDEMA 48
911 PRODUCT ADMINISTRATION ERROR 48
912 SOFT TISSUE INFECTION 48
913 APLASIA PURE RED CELL 47
914 ATYPICAL PNEUMONIA 47
915 DYSAESTHESIA 47
916 FEAR 47
917 HYPERAESTHESIA 47
918 METASTATIC NEOPLASM 47
919 NOCTURIA 47
920 RED BLOOD CELL SEDIMENTATION RATE INCREASED 47
921 THROMBOCYTOSIS 47
922 TUMOUR MARKER INCREASED 47
923 UTERINE ENLARGEMENT 47
924 DRUG EFFECT DECREASED 46
925 DYSKINESIA 46
926 GUILLAIN-BARRE SYNDROME 46
927 HISTIOCYTOSIS HAEMATOPHAGIC 46
928 MALIGNANT MELANOMA 46
929 NEPHROTIC SYNDROME 46
930 PERFORMANCE STATUS DECREASED 46
931 POST PROCEDURAL COMPLICATION 46
932 PRODUCT LABEL CONFUSION 46
933 RENAL TUBULAR NECROSIS 46
934 STENOTROPHOMONAS INFECTION 46
935 TROPONIN INCREASED 46
936 AGGRESSION 45
937 BLOOD PRESSURE ABNORMAL 45
938 BODY TEMPERATURE ABNORMAL 45
939 BRAIN FOG 45
940 CLOSTRIDIUM TEST POSITIVE 45
941 DERMATITIS CONTACT 45
942 DEVICE OPERATIONAL ISSUE 45
943 DEVICE USE ISSUE 45
944 EMOTIONAL DISORDER 45
945 EYE IRRITATION 45
946 FIBROSIS 45
947 HYPOAESTHESIA ORAL 45
948 PANIC ATTACK 45
949 PNEUMONIA CYTOMEGALOVIRAL 45
950 PSORIASIS 45
951 ACCIDENTAL OVERDOSE 44
952 ACUTE HEPATIC FAILURE 44
953 BLOOD CREATININE DECREASED 44
954 DERMATITIS EXFOLIATIVE GENERALISED 44
955 ENGRAFT FAILURE 44
956 FISTULA 44
957 HYPERPHOSPHATAEMIA 44
958 LIVER ABSCESS 44
959 MONOPLEGIA 44
960 MOUTH HAEMORRHAGE 44
961 NEUROLOGICAL DECOMPENSATION 44
962 NON-SMALL CELL LUNG CANCER 44
963 ONYCHOCLASIS 44
964 OVARIAN CANCER 44
965 PERIODONTITIS 44
966 PRODUCT PACKAGING ISSUE 44
967 RHEUMATOID ARTHRITIS 44
968 TERMINAL STATE 44
969 TRIPLE NEGATIVE BREAST CANCER 44
970 VIRAL HAEMORRHAGIC CYSTITIS 44
971 ACIDOSIS 43
972 FUNGAEMIA 43
973 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 43
974 HAEMODYNAMIC INSTABILITY 43
975 NASAL DISORDER 43
976 NODULE 43
977 OTITIS MEDIA 43
978 PSEUDOMEMBRANOUS COLITIS 43
979 RENAL INJURY 43
980 VENTRICULAR EXTRASYSTOLES 43
981 ABDOMINAL MASS 42
982 APPENDICITIS 42
983 ARTERIOSCLEROSIS 42
984 BLOOD CALCIUM INCREASED 42
985 CHOLANGITIS 42
986 FEMUR FRACTURE 42
987 INTERVERTEBRAL DISC DISORDER 42
988 LOWER GASTROINTESTINAL HAEMORRHAGE 42
989 LYMPHOCYTOSIS 42
990 MICTURITION URGENCY 42
991 MYOSITIS 42
992 PLEURITIC PAIN 42
993 PSYCHOTIC DISORDER 42
994 PYODERMA GANGRENOSUM 42
995 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 41
996 BREATH SOUNDS ABNORMAL 41
997 CRYING 41
998 GASTROINTESTINAL INFLAMMATION 41
999 HAEMODIALYSIS 41